Nu Skin Enterprises' (NYSE:NUS) Profits May Not Reveal Underlying Issues
Nu Skin Enterprises' recent solid earnings report might be misleading due to a significant boost from unusual items. Investors are advised to look beyond statutory profits, as these unusual gains are unlikely to recur, suggesting the company's underlying profitability may be lower. The article suggests considering other factors like return on equity and insider ownership for a comprehensive understanding.
Nu Skin Enterprises director Laura Nathanson sells $18,009 in shares By Investing.com
Nu Skin Enterprises director Laura Nathanson sold 2,676 shares of Class A Common Stock for $18,009 on May 11, 2026. This transaction occurred as NUS stock trades near its 52-week low, despite InvestingPro analysis suggesting it is significantly undervalued. The sale follows Nu Skin's first-quarter 2026 earnings, which missed analyst expectations for EPS and revenue.
Nu Skin Enterprises director Laura Nathanson sells $18,009 in shares
Nu Skin Enterprises director Laura Nathanson sold 2,676 shares of the company's Class A Common Stock for $18,009 on May 11, 2026. This insider sale occurred as NUS stock trades near its 52-week low, despite InvestingPro analysis suggesting the stock is significantly undervalued. The company recently reported Q1 2026 earnings and revenue that missed analyst expectations, leading to a decline in stock price.
Charles Schwab holds 2.14M Nu Skin shares (NUS) — 4.45% stake
Charles Schwab Investment Management Inc. has filed an amended Schedule 13G, disclosing a 4.45% ownership stake in Nu Skin Enterprises' Class A Common Stock, totaling 2,143,294 shares. The filing indicates Charles Schwab holds sole voting and dispositive power over these shares. This passive investment is below the 5% threshold, signifying no intent to influence corporate governance or control.
Nu Skin Enterprises director Laura Nathanson sells $18,009 in shares By Investing.com
Nu Skin Enterprises director Laura Nathanson sold 2,676 shares of the company's Class A Common Stock for $18,009. This transaction occurred on May 11, 2026, with the stock trading near its 52-week low. The sale follows disappointing first-quarter earnings that fell short of analyst expectations, leading to a decline in Nu Skin's stock price.
Nu Skin Enterprises director Laura Nathanson sells $18,009 in shares
Nu Skin Enterprises director Laura Nathanson sold 2,676 shares of Class A Common Stock for $18,009 on May 11, 2026. This transaction follows a period where NUS stock trades near its 52-week low and the company reported Q1 2026 earnings and revenue below analyst expectations. Nathanson now holds 30,473 shares directly.
Nu Skin Enterprises director Laura Nathanson sells $18,009 in shares By Investing.com
Nu Skin Enterprises director Laura Nathanson sold 2,676 shares of Class A Common Stock for a total of $18,009. The sale occurred on May 11, 2026 and comes as the stock trades near its 52-week low. Despite a recent decline in stock price and first-quarter earnings missing analyst expectations, InvestingPro analysis indicates the stock may be significantly undervalued.
Nu Skin Enterprises director Laura Nathanson sells $18,009 in shares
Laura Nathanson, a director at Nu Skin Enterprises (NYSE:NUS), sold 2,676 shares of Class A Common Stock for a total of $18,009 on May 11, 2026. This insider sale occurred as NUS stock approached its 52-week low. The company recently reported first-quarter 2026 earnings below analyst expectations, with adjusted EPS of $0.14 and revenue of $320.6 million.
[Form 4] NU SKIN ENTERPRISES, INC. Insider Trading Activity
Nu Skin Enterprises director Laura Nathanson sold 2,676 shares of Class A Common Stock at $6.73 per share in an open-market transaction. Following the sale, she directly holds 30,473 shares, indicating the transaction was a relatively small portion of her total holdings and is likely a routine liquidity event rather than a change in her investment thesis. The Form 4 filing confirmed this non-derivative transaction and provided details on her remaining direct beneficial ownership.
Nu Skin (NUS) Form 144: William Blair named for 49.5M Class A share listing
Nu Skin Enterprises filed a Form 144 notice revealing a proposed sale of 49,497,715 Class A common shares through William Blair and Company LLC on the NYSE, dated May 11, 2026. The filing also detailed prior compensatory dispositions of Class A shares on April 30, 2024, and May 29, 2025. This notice indicates potential trading activity for a significant number of Nu Skin's Class A shares.
Nu Skin Enterprises (NUS) One Off Gain Raises Questions For Earnings Decline Narratives
Nu Skin Enterprises (NUS) reported FY 2025 results with a significant one-off gain of US$151.0 million, which boosted its reported profitability to US$3.25 EPS for the trailing twelve months. Despite this gain and a current P/E of 2.2x, the company faces skepticism due to a 38.5% historical decline in earnings and a forecasted 51.6% yearly decline over the next three years, along with modest 1.5% revenue growth outlook. The article questions the durability of current margins and highlights the tension between the low P/E valuation and the weak earnings trajectory.
Nu Skin (NYSE: NUS) product chief resigns but remains strategic advisor
Nu Skin Enterprises (NYSE: NUS) announced that Steven K. Hatchett has resigned from his position as Executive Vice President and Chief Product Officer, effective May 8, 2026, due to family health circumstances. He will continue to serve the company as a strategic product advisor with an annual salary of $147,478. The company expressed appreciation for his contributions as Chief Product Officer.
Nu Skin (NYSE: NUS) Q1 2026 sales drop 12% as earnings shrink
Nu Skin Enterprises reported a significant decline in its Q1 2026 financial performance, with revenue falling 12% to $320.6 million and net income plummeting to $1.8 million from $107.5 million in the prior-year quarter. The drop in earnings is largely attributed to the absence of a large gain from the sale of the Mavely business seen in Q1 2025, combined with $5.9 million in charges related to winding down the BeautyBio business and ongoing macroeconomic pressures affecting consumer spending and customer acquisition. The company is focusing on business model optimization, the rollout of its Prysm iO wellness platform, and expansion into India to counter these challenges, while maintaining a manageable debt level and continuing capital returns through dividends and share repurchases.
Working capital per share of Nu Skin Enterprises, Inc. Class A – TRADEGATE:NUS
The article provides information regarding the working capital per share for Nu Skin Enterprises, Inc. Class A (TRADEGATE:NUS) on TradingView. It indicates that the market is closed and offers navigation to financial data, news, and community sections for the company.
NUS SEC Filings - Nu Skin Enter 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Nu Skin Enterprises (NUS) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider trading forms. It features details about the company's financial performance, business model, and recent insider transactions. The platform also offers AI-powered summaries of these filings to help investors quickly grasp key insights.
Nu Skin Enterprises to Announce First Quarter 2026 Financial Results
Nu Skin Enterprises (NYSE: NUS) announced it will release its first-quarter 2026 financial results after market close on Thursday, May 7, 2026. Management will host a conference call at 5 p.m. ET on the same day to discuss the results and upcoming business initiatives. A webcast of the conference call and financial information will be available on the company's investor relations website.
Nu Skin (NUS) outlines 2026 votes, 2025 results and CEO pay in proxy
Nu Skin Enterprises (NUS) released its definitive proxy statement outlining proposals for its May 28, 2026 annual meeting, including the election of nine directors, an advisory vote on executive compensation, approval of an amended incentive plan, and auditor ratification. The company detailed its 2025 financial performance, reporting $1.49 billion in revenue and showcasing its performance-based executive pay structure, which resulted in reduced cash incentives due to financial metrics falling below target levels. CEO Ryan Napierski's 2025 compensation totaled $5.97 million, predominantly equity-based, and the company emphasized strong corporate governance practices and sustainability initiatives.
Nu Skin Launches Prysm iO™: A Revolutionary AI-Powered Platform for Personalized Nutritional Wellness
Nu Skin Enterprises Inc. has launched Prysm iO™, an AI-powered platform designed to provide personalized nutritional wellness insights to consumers in the U.S., with global expansion planned. This intelligent device noninvasively scans fingertip carotenoid levels in 15 seconds, offering a "Nutrition Health Score" based on over two decades of research and a database of 20 million antioxidant scans. Prysm iO aims to empower users to make informed wellness decisions and track the effectiveness of their nutrition and supplement routines, integrating with Nu Skin's existing wellness ecosystem.
Nu Skin (NUS) CFO Chelsea Lantz discloses 42,100-share Class A stake
Nu Skin Enterprises' Chief Financial Officer, Chelsea K. Lantz, has filed an initial Form 3, disclosing her beneficial ownership of 42,100 shares of Class A Common Stock. This filing establishes her equity position as an executive officer. The Form 3 is an initial statement and does not represent a buy or sell transaction.
Nu Skin (NYSE: NUS) adds $175M term loan and $75M revolver
Nu Skin Enterprises (NYSE: NUS) has secured a new Second Amended and Restated Credit Agreement on March 27, 2026, establishing a $175 million term loan and a $75 million revolving credit facility, both with five-year terms. The term loan was fully drawn at closing to refinance its prior bank debt, effectively reshaping its financing structure without adding new net debt. The new agreement includes financial covenants such as a maximum consolidated leverage ratio of 2.25 to 1.00 and a minimum interest coverage ratio of 3.00 to 1.00.
Vanguard disaggregates holdings; reports 0 shares of Nu Skin (NYSE: NUS)
The Vanguard Group has reported holding 0 shares (0%) of Nu Skin Enterprises Inc. (NYSE: NUS) common stock following an internal realignment on January 12, 2026. This change is due to certain Vanguard subsidiaries now reporting their beneficial ownership separately, as permitted by SEC Release No. 34-39538. The Schedule 13G/A filing, signed by Ashley Grim, Head of Global Fund Administration, indicates that Vanguard is no longer deemed to beneficially own securities held by these disaggregated subsidiaries.
CFO change at Nu Skin (NYSE: NUS) as Chelsea Lantz steps in
Nu Skin Enterprises announced that its EVP and CFO, James D. Thomas, resigned on March 17, 2026. The company's board has appointed Chelsea K. Lantz, Vice President and Corporate Controller, as interim CFO, effective March 18, 2026, while a search for a permanent replacement is underway. Lantz, who has been with Nu Skin since 2011, will receive an annual salary of $300,000, a 35% target incentive bonus, and a $25,000 quarterly stipend in her interim role.
NU SKIN ENTERPRISES, INC.
This article announces that Nu Skin Enterprises Inc. filed a Form 8K for March 20. The filing was published on March 20, 2026, at 04:20 PM. The text also displays current trading data for NUS stock and various market indices.
Nu Skin Enterprises Appoints Chelsea Lantz as Interim Chief Financial Officer
Nu Skin Enterprises has appointed Chelsea Lantz as its interim Chief Financial Officer, effective immediately. This appointment follows James Thomas's departure to pursue another opportunity. Lantz, who previously served as corporate controller and led cost-improvement efforts, will help guide the company's financial transformation while a search for a permanent CFO is underway.
Portolan Capital Management LLC Purchases Shares of 596,724 Nu Skin Enterprises, Inc. $NUS
Portolan Capital Management LLC has acquired 596,724 shares of Nu Skin Enterprises (NYSE:NUS) with a value of approximately $7.27 million, representing a 1.21% ownership stake. This move is part of broader institutional interest in Nu Skin, with other firms like Prudential and American Century also increasing their holdings. Despite these investments, Nu Skin recently missed EPS and revenue estimates and has received mixed to negative analyst ratings.
NU SKIN (NUS) CEO Ryan Napierski receives 282,353-share equity grant
NU SKIN ENTERPRISES, INC. President and CEO Ryan S. Napierski was granted 282,353 shares of Class A Common Stock on March 6, 2026, increasing his direct holdings to 1,001,905 shares. The shares were acquired at $0.00 per share as an award, indicated by a transaction code "A" on the SEC Form 4 filing. This filing does not report any sales or disposals by the CEO.
Nu Skin (NUS) Chief Product Officer granted 77,941 Class A shares in Form 4
Nu Skin Enterprises' Chief Product Officer, Steven Keith Hatchett, was granted 77,941 shares of Class A common stock on March 6, 2026, as reported in a Form 4 SEC filing. This non-cash award at $0.00 per share increased Hatchett's direct ownership to 260,818 shares. The transaction code "A" confirms it was a grant or award acquisition, not a stock purchase.
Nu Skin (NUS) EVP Justin Keisel receives 47,059-share equity grant
Justin S. Keisel, EVP and President of Global Sales at Nu Skin Enterprises, Inc. (NUS), received an equity grant of 47,059 shares of Class A Common Stock. This grant was awarded at $0.00 per share, indicating it was an equity grant rather than a market purchase. Following this transaction, Keisel directly holds 160,170 shares of Nu Skin Class A Common Stock.
Nu Skin (NYSE: NUS) EVP granted 138,971 Class A common shares
Nu Skin Enterprises EVP, COO, and CLO Chayce David Clark was granted 138,971 Class A Common Stock shares on March 6, 2026, increasing his direct ownership to 390,746 shares. This transaction, revealed in an SEC Form 4 filing, was a company-issued equity award rather than a market purchase. The grant highlights an increase in his beneficial ownership with no acquisition cost.
NU SKIN (NUS) CFO receives 114,706-share Class A stock grant
NU SKIN (NUS) Chief Financial Officer Thomas James D was granted 114,706 shares of Class A Common Stock on March 6, 2026, at a price of $0.00 per share. This stock grant increased his directly held Class A Common Stock position to 267,102 shares. The transaction was an equity award, not an open-market purchase, and is coded as a grant, award, or other acquisition on the SEC Form 4 filing.
Segall Bryant & Hamill LLC Has $809,000 Stock Position in Nu Skin Enterprises, Inc. $NUS
Segall Bryant & Hamill LLC significantly reduced its stake in Nu Skin Enterprises (NYSE:NUS) by 66.5% during the third quarter, now holding shares worth $809,000. Despite this, institutional investors collectively own 82.84% of the company. Recent analyst downgrades and a slight miss on quarterly earnings have led to an average "Reduce" rating for Nu Skin.
Nu Skin (NUS) CEO has 124,802 shares withheld to cover taxes
Nu Skin Enterprises CEO Ryan S. Napierski had 124,802 Class A common shares withheld at a price of $8.63 per share to cover tax obligations related to the vesting of previously granted restricted stock units. This transaction, indicated by an "F" code in the SEC Form 4 filing, is a common administrative procedure and not an open-market sale. After this tax-withholding disposition, Napierski directly holds 719,552 Nu Skin Class A common shares.
Nu Skin (NUS) EVP Clark has 45,502 shares withheld for RSU taxes
Nu Skin Enterprises EVP and General Counsel Chayce David Clark reported that 45,502 shares of Class A common stock were withheld to cover tax obligations related to the vesting of restricted stock units. The shares were withheld at $8.63 each in a non-open-market transaction. Following this, Clark directly holds 251,775 shares of Nu Skin Enterprises Class A common stock.
Nu Skin (NUS) CPO has 26,001 shares withheld for taxes
Nu Skin Enterprises' Chief Product Officer, Steven Keith Hatchett, had 26,001 shares of Class A common stock withheld on February 26, 2026, to cover tax obligations arising from the vesting of Restricted Stock Units. These shares were recorded at $8.63 per share, and following this transaction, Hatchett directly owns 182,877 shares. This transaction was not an open-market sale but a tax-related disposition.
Nu Skin (NUS) CFO has shares withheld to cover RSU tax obligations
Nu Skin Enterprises' CFO, Thomas James, reported a Form 4 transaction where 28,602 shares of Class A Common Stock were disposed of at $8.63 per share on February 26, 2026. These shares were withheld to cover tax obligations arising from previously vested restricted stock units, not an open-market sale. After this transaction, James directly holds 152,396 shares of Nu Skin Class A Common Stock.
Nu Skin (NUS) executive sees shares withheld to cover tax obligations
Nu Skin Enterprises executive Justin S. Keisel had 13,687 shares of Class A common stock withheld on February 26, 2026, to cover tax obligations. This disposition, valued at $8.63 per share, was related to the vesting of previously granted restricted stock units and
BWMX: 4Q Review: Cleaning Up in 2025 Ahead of Game Changing 2026; Reiterate Buy, $30 PT
Research Tree reiterates its Buy rating and $30 price target for Betterware de Mexico (BWMX) despite 4Q25 results slightly below expectations due to a weak Mexican consumer, inventory clearing, FX issues, and JAFRA incentive shifts. The company anticipates organic mid-single digit top-line expansion driven by a more stable Mexican consumer and significant growth from the expected 2Q close of Tupperware LatAm operations in 2026. The report slightly lowers 2026 projections but rolls out solid 2027 expansion forecasts.
BWMX: 4Q Preview: Expansion, Returns Drive EPS Growth into 2026 (and Beyond)
Betterware de Mexico is expected to report strong 2026 results, driven by the Tupperware LatAm acquisition, continued high-margin growth at JAFRA, focus on returns, a weak USD, and normalization of China trade. Analyst Eric Beder reiterates a Buy rating and a $30 price target for BWMX, despite a slight tweak down in 4Q25 margin projections. The company is set to report 4Q25 results after the close on February 26th and is poised for material expansion into Central and South America.
Nu Skin (NUS) EVP Keisel has 1,534 shares withheld to cover RSU taxes
Nu Skin Enterprises, Inc. (NUS) EVP Justin S. Keisel reported a tax-related disposition where 1,534 shares of Class A Common Stock were withheld at $8.36 per share. This action was taken to cover tax obligations arising from the vesting of restricted stock units (RSUs). Following this non-open-market transaction, Keisel directly holds 126,798 shares.
Nu Skin Acquires 3i Solutions
Nu Skin Enterprises, Inc. has acquired 3i Solutions, an ingredients company specializing in proprietary encapsulation technology for cosmetics, food, and nutritional industries. This acquisition is expected to enhance Nu Skin's product innovation and formulation performance by leveraging 3i Solutions' expertise in creating water-dispersible oil-soluble materials. The CEO of Nu Skin, Ritch Wood, stated that the acquisition will benefit their sales force and consumers through improved absorption of nutritional ingredients, innovative delivery methods, controlled release of active ingredients, and new product formats.
Nu Skin (NUS) CEO has 49,037 shares withheld for tax obligations
Nu Skin Enterprises CEO Ryan S. Napierski had 49,037 shares of Class A common stock, valued at $8.36 per share, withheld on February 15, 2026, to cover tax obligations arising from vested restricted stock units. This transaction is a common administrative procedure, not an open-market sale. After the withholding, Napierski directly held 844,354 shares of Class A common stock.
Nu Skin (NYSE: NUS) EVP withholds 17,947 shares to cover taxes
Nu Skin Enterprises EVP and General Counsel Chayce David Clark had 17,947 shares of Class A common stock withheld at $8.36 per share to cover tax obligations related to the vesting of restricted stock units. After this transaction, Clark directly owns 297,277 shares. This was a tax-withholding disposition, not an open-market sale.
Nu Skin Enterprises, Inc. (NYSE:NUS) Declares Quarterly Dividend of $0.06
Nu Skin Enterprises (NYSE:NUS) has announced a quarterly dividend of $0.06 per share, payable on March 11th to shareholders of record by February 27th. This amounts to an annualized dividend of $0.24, representing a yield of approximately 2.3%. The company's dividend is well-covered by earnings, with a payout ratio of 32% and a projected future payout ratio of 22.2%.
Nu Skin Enterprises (NYSE:NUS) Short Interest Falls in Russell 1000
The article reports that Nu Skin Enterprises (NYSE:NUS) has seen a drop in its short interest within the Russell 1000 index. It covers the movement of short interest, institutional filings, and the operating structure of the company in the consumer wellness and direct selling sector. The content also provides a brief overview of what short interest, institutional ownership filings, and a direct selling model signify.
Should You Sell Your Stake in Nu Skin Enterprises (NUS)?
Aristotle Capital Boston's Small Cap Equity Fund liquidated its position in Nu Skin Enterprises (NYSE: NUS) due to deteriorated fundamental performance and an uncertain strategic transformation outlook. Despite its strong past twelve-month performance, the company saw a significant one-month decline. The article highlights that Nu Skin is not among the 30 most popular stocks among hedge funds, suggesting that AI stocks might offer greater return potential.
Short Interest in Nu Skin Enterprises, Inc. (NYSE:NUS) Drops By 16.0%
Nu Skin Enterprises (NYSE:NUS) experienced a 16.0% decrease in short interest in January, totaling 1,758,724 shares as of January 30th. This represents about 3.7% of shares outstanding with a days-to-cover ratio of 3.0 days. The company recently missed Q4 earnings estimates, but declared a quarterly dividend of $0.06 and is largely held by institutional investors with a "Hold" consensus rating from analysts.
Performance awards lift Nu Skin (NYSE: NUS) EVP’s holdings to 128,332 shares
Nu Skin Enterprises EVP Justin S. Keisel received 37,410 Class A common shares as performance-based stock awards on February 10, 2026. These awards, granted at $0.00 per share, were tied to the company meeting specific performance criteria from 2024 and 2025 restricted stock unit grants. Following these transactions, Keisel's direct holdings in Nu Skin (NYSE: NUS) increased to 128,332 shares.
Nu Skin Enterprises, Inc. (NYSE:NUS) Q4 2025 Earnings Call Transcript
Nu Skin Enterprises, Inc. (NYSE: NUS) reported its Q4 2025 earnings, with EPS slightly missing expectations but showing a strong 51% growth year-over-year. The company is undergoing a strategic transformation, centered on the launch of Prism IO, an intelligent wellness platform, and expansion into emerging markets like India. Nu Skin anticipates returning to growth by late 2026, driven by these initiatives and continued operational efficiency improvements.
$1 EPS outlook and India launch: inside Nu Skin’s 2026 plan
Nu Skin Enterprises (NYSE: NUS) reported Q4 2025 revenue of $370.3M and adjusted EPS of $0.29, which was at the high end of their guidance despite missing Stonegate Capital's revenue estimates. The company highlighted robust gross margins, disciplined spending, and strategic expansion into India, with a full launch expected in the second half of 2026. Nu Skin projects a FY26 EPS midpoint of $1.00 as it focuses on its Prysm iO rollout and geographic growth initiatives.
Top 3 Defensive Stocks That May Rocket Higher In February
This article identifies three oversold consumer staple stocks—Nu Skin Enterprises (NUS), Coty Inc (COTY), and The Honest Company (HNST)—that may be poised for a rebound in February due to their low Relative Strength Index (RSI) values. Each company's recent financial performance and stock action are mentioned, highlighting potential buying opportunities for investors. The article is based on analysis from Benzinga Pro.
